Premium
Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome
Author(s) -
Moore Alexandra,
Burrows Amanda K.,
Malik Richard,
Ghubash Rudayna M.,
Last Robert D.,
Remaj Benjamin
Publication year - 2022
Publication title -
veterinary dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.744
H-Index - 60
eISSN - 1365-3164
pISSN - 0959-4493
DOI - 10.1111/vde.13097
Subject(s) - feline immunodeficiency virus , toxoplasmosis , toxoplasma gondii , medicine , virology , cats , protozoan parasite , human immunodeficiency virus (hiv) , immunology , lentivirus , viral disease , antibody , parasite hosting , world wide web , computer science
Toxoplasma gondii is a ubiquitous protozoan, for which felids are the definitive host. Immunocompromised individuals are susceptible to recrudescent toxoplasmosis. This case describes a 6‐year‐old, feline immunodeficiency virus‐positive domestic short hair cat with feline atopic skin syndrome that developed fatal toxoplasmosis after treatment with oclacitinib for five months.